AstraZeneca PLC (AZN)
188.94
+5.06
(+2.75%)
USD |
NYSE |
Nov 04, 13:41
AstraZeneca Total Return Price : 188.94 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 183.88 |
| November 02, 2026 | 186.58 |
| October 30, 2026 | 186.65 |
| October 29, 2026 | 174.40 |
| October 28, 2026 | 169.51 |
| October 27, 2026 | 170.08 |
| October 26, 2026 | 172.06 |
| October 23, 2026 | 171.49 |
| October 22, 2026 | 172.57 |
| October 21, 2026 | 168.45 |
| October 20, 2026 | 168.82 |
| October 19, 2026 | 163.95 |
| October 16, 2026 | 165.41 |
| October 15, 2026 | 166.68 |
| October 14, 2026 | 162.03 |
| October 13, 2026 | 155.82 |
| October 12, 2026 | 158.33 |
| October 09, 2026 | 159.20 |
| October 08, 2026 | 158.78 |
| October 07, 2026 | 160.12 |
| October 06, 2026 | 158.61 |
| October 05, 2026 | 156.53 |
| October 02, 2026 | 156.90 |
| October 01, 2026 | 157.70 |
| September 30, 2026 | 161.47 |
| Date | Value |
|---|---|
| September 29, 2026 | 164.21 |
| September 28, 2026 | 166.15 |
| September 25, 2026 | 166.58 |
| September 24, 2026 | 164.56 |
| September 23, 2026 | 163.33 |
| September 22, 2026 | 168.37 |
| September 21, 2026 | 168.10 |
| September 18, 2026 | 166.08 |
| September 17, 2026 | 166.14 |
| September 16, 2026 | 162.89 |
| September 15, 2026 | 161.85 |
| September 14, 2026 | 163.78 |
| September 11, 2026 | 160.17 |
| September 10, 2026 | 159.64 |
| September 09, 2026 | 156.94 |
| September 08, 2026 | 160.04 |
| September 04, 2026 | 162.70 |
| September 03, 2026 | 164.77 |
| September 02, 2026 | 161.63 |
| September 01, 2026 | 162.47 |
| August 31, 2026 | 162.13 |
| August 28, 2026 | 162.70 |
| August 27, 2026 | 164.52 |
| August 26, 2026 | 166.27 |
| August 25, 2026 | 169.66 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| GSK Plc | 51.12 |
| Johnson & Johnson | 274.38 |
| Eli Lilly & Co. | 1419.08 |
| Merck & Co., Inc. | 148.85 |
| Novo Nordisk A/S | 42.79 |